Russell William Jenkins, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Sphingomyelin Phosphodiesterase | 14 | 2015 | 82 | 2.570 |
Why?
|
Spheroids, Cellular | 4 | 2023 | 330 | 1.020 |
Why?
|
Ceramides | 12 | 2013 | 201 | 0.900 |
Why?
|
Molecular Targeted Therapy | 5 | 2020 | 2811 | 0.720 |
Why?
|
Immunotherapy | 8 | 2023 | 4652 | 0.720 |
Why?
|
Sphingosine | 7 | 2013 | 308 | 0.690 |
Why?
|
Sphingolipids | 6 | 2013 | 174 | 0.680 |
Why?
|
Immunologic Factors | 2 | 2020 | 1589 | 0.670 |
Why?
|
Immune Evasion | 1 | 2023 | 363 | 0.660 |
Why?
|
Drug Resistance, Neoplasm | 5 | 2023 | 5305 | 0.660 |
Why?
|
Lysosomes | 5 | 2012 | 924 | 0.560 |
Why?
|
Acid Ceramidase | 2 | 2017 | 21 | 0.520 |
Why?
|
Melanoma | 5 | 2020 | 5709 | 0.470 |
Why?
|
Neoplasms | 9 | 2024 | 22170 | 0.470 |
Why?
|
Lab-On-A-Chip Devices | 1 | 2018 | 432 | 0.460 |
Why?
|
Protein Kinase Inhibitors | 5 | 2020 | 5671 | 0.460 |
Why?
|
Cell Culture Techniques | 2 | 2018 | 1667 | 0.450 |
Why?
|
Immunity, Innate | 2 | 2024 | 3065 | 0.450 |
Why?
|
Tumor Microenvironment | 2 | 2024 | 3877 | 0.440 |
Why?
|
Leukemia, Monocytic, Acute | 1 | 2012 | 58 | 0.420 |
Why?
|
Chin | 1 | 2012 | 38 | 0.410 |
Why?
|
Immunity | 1 | 2018 | 996 | 0.410 |
Why?
|
Chemokine CCL5 | 3 | 2016 | 214 | 0.410 |
Why?
|
Hypesthesia | 1 | 2012 | 107 | 0.400 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2015 | 571 | 0.360 |
Why?
|
Tumor Escape | 3 | 2024 | 370 | 0.340 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 1 | 2013 | 269 | 0.340 |
Why?
|
Cell Line, Tumor | 20 | 2021 | 16981 | 0.320 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2017 | 2057 | 0.290 |
Why?
|
Endopeptidases | 1 | 2010 | 774 | 0.280 |
Why?
|
Protein Precursors | 1 | 2010 | 1132 | 0.270 |
Why?
|
Up-Regulation | 3 | 2013 | 4124 | 0.260 |
Why?
|
Lysophospholipids | 4 | 2012 | 338 | 0.250 |
Why?
|
Cyclin-Dependent Kinase 6 | 2 | 2018 | 350 | 0.250 |
Why?
|
Interleukin-1beta | 1 | 2010 | 999 | 0.240 |
Why?
|
Pyrazoles | 1 | 2015 | 2009 | 0.230 |
Why?
|
Cyclin-Dependent Kinase 4 | 2 | 2018 | 561 | 0.230 |
Why?
|
Signal Transduction | 10 | 2024 | 23445 | 0.220 |
Why?
|
Skin Neoplasms | 2 | 2020 | 5821 | 0.220 |
Why?
|
Tumor Necrosis Factors | 1 | 2023 | 107 | 0.210 |
Why?
|
Pyridines | 1 | 2015 | 2875 | 0.210 |
Why?
|
Protein Processing, Post-Translational | 1 | 2010 | 1974 | 0.210 |
Why?
|
Autophagy | 2 | 2024 | 1326 | 0.210 |
Why?
|
STAT Transcription Factors | 1 | 2023 | 188 | 0.200 |
Why?
|
Janus Kinases | 1 | 2023 | 248 | 0.190 |
Why?
|
Oxidoreductases | 3 | 2011 | 413 | 0.180 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2010 | 4352 | 0.170 |
Why?
|
Caspases | 1 | 2023 | 879 | 0.170 |
Why?
|
Animals | 24 | 2024 | 168459 | 0.170 |
Why?
|
Dioxygenases | 1 | 2022 | 345 | 0.170 |
Why?
|
Single-Cell Analysis | 2 | 2021 | 2449 | 0.170 |
Why?
|
MAP Kinase Kinase Kinase 1 | 1 | 2018 | 56 | 0.150 |
Why?
|
Glucosylceramidase | 2 | 2009 | 127 | 0.150 |
Why?
|
Adenocarcinoma | 2 | 2016 | 6346 | 0.150 |
Why?
|
T-Lymphocytes | 4 | 2022 | 10194 | 0.150 |
Why?
|
Nitrobenzenes | 1 | 2017 | 66 | 0.150 |
Why?
|
Antineoplastic Agents | 6 | 2020 | 13639 | 0.140 |
Why?
|
Interferon-gamma | 2 | 2023 | 3162 | 0.140 |
Why?
|
Endogenous Retroviruses | 1 | 2018 | 111 | 0.140 |
Why?
|
Propanolamines | 1 | 2017 | 163 | 0.140 |
Why?
|
Time-Lapse Imaging | 1 | 2017 | 194 | 0.140 |
Why?
|
Organoids | 1 | 2023 | 740 | 0.140 |
Why?
|
Cholangiocarcinoma | 1 | 2022 | 552 | 0.130 |
Why?
|
Bile Duct Neoplasms | 1 | 2022 | 605 | 0.130 |
Why?
|
Humans | 42 | 2024 | 761504 | 0.130 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2017 | 332 | 0.130 |
Why?
|
Gene Expression Regulation, Neoplastic | 5 | 2021 | 8547 | 0.130 |
Why?
|
Neoplasms, Experimental | 1 | 2021 | 1229 | 0.130 |
Why?
|
Prodrugs | 1 | 2017 | 261 | 0.120 |
Why?
|
Mice | 15 | 2022 | 81525 | 0.120 |
Why?
|
Ceramidases | 2 | 2011 | 4 | 0.120 |
Why?
|
Niemann-Pick Diseases | 2 | 2012 | 27 | 0.120 |
Why?
|
Interferons | 1 | 2018 | 706 | 0.120 |
Why?
|
Lung Neoplasms | 2 | 2018 | 13380 | 0.120 |
Why?
|
RNA Splice Sites | 1 | 2015 | 211 | 0.110 |
Why?
|
Neutral Ceramidase | 1 | 2012 | 1 | 0.110 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2018 | 1745 | 0.110 |
Why?
|
Benzimidazoles | 1 | 2018 | 858 | 0.110 |
Why?
|
Tumor Cells, Cultured | 2 | 2017 | 6132 | 0.100 |
Why?
|
Immunophenotyping | 1 | 2017 | 1870 | 0.100 |
Why?
|
Mutation | 7 | 2022 | 30052 | 0.100 |
Why?
|
Daunorubicin | 1 | 2012 | 156 | 0.100 |
Why?
|
Retinal Pigment Epithelium | 1 | 2015 | 303 | 0.100 |
Why?
|
Cytokines | 3 | 2017 | 7396 | 0.100 |
Why?
|
Farber Lipogranulomatosis | 1 | 2011 | 2 | 0.100 |
Why?
|
Caspase 7 | 1 | 2011 | 50 | 0.090 |
Why?
|
Leukocytosis | 1 | 2012 | 251 | 0.090 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2017 | 803 | 0.090 |
Why?
|
Glycosphingolipids | 1 | 2011 | 73 | 0.090 |
Why?
|
Protein Kinase C | 4 | 2009 | 1202 | 0.090 |
Why?
|
Ribosomal Protein S6 Kinases | 1 | 2011 | 203 | 0.090 |
Why?
|
Cytarabine | 1 | 2012 | 697 | 0.090 |
Why?
|
Mitogen-Activated Protein Kinase 13 | 1 | 2009 | 1 | 0.080 |
Why?
|
Intracellular Space | 1 | 2010 | 197 | 0.080 |
Why?
|
Glucosylceramides | 1 | 2009 | 28 | 0.080 |
Why?
|
Galactosylgalactosylglucosylceramidase | 1 | 2008 | 4 | 0.080 |
Why?
|
Lipoproteins, LDL | 1 | 2012 | 642 | 0.080 |
Why?
|
Pancreatitis | 1 | 2016 | 1096 | 0.080 |
Why?
|
Caloric Restriction | 1 | 2011 | 299 | 0.080 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2012 | 646 | 0.080 |
Why?
|
Neoplasm Proteins | 1 | 2021 | 3617 | 0.080 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2012 | 678 | 0.080 |
Why?
|
Extracellular Space | 1 | 2010 | 563 | 0.080 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2021 | 4580 | 0.080 |
Why?
|
Blotting, Western | 3 | 2010 | 5035 | 0.080 |
Why?
|
Tretinoin | 1 | 2011 | 519 | 0.080 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2018 | 2917 | 0.070 |
Why?
|
Dependovirus | 1 | 2012 | 718 | 0.070 |
Why?
|
Protein Kinase C-delta | 1 | 2007 | 114 | 0.070 |
Why?
|
Flow Cytometry | 1 | 2017 | 5869 | 0.070 |
Why?
|
Lymphocyte Activation | 1 | 2017 | 5486 | 0.070 |
Why?
|
Translocation, Genetic | 1 | 2012 | 1393 | 0.070 |
Why?
|
Serine | 1 | 2010 | 830 | 0.070 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2011 | 1171 | 0.070 |
Why?
|
Ultraviolet Rays | 2 | 2011 | 1080 | 0.070 |
Why?
|
Phagocytosis | 1 | 2012 | 1528 | 0.070 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 4575 | 0.070 |
Why?
|
Amino Acid Substitution | 1 | 2010 | 1738 | 0.060 |
Why?
|
Carcinoma, Renal Cell | 1 | 2021 | 3164 | 0.060 |
Why?
|
Transfection | 2 | 2010 | 5774 | 0.060 |
Why?
|
Microfilament Proteins | 1 | 2010 | 1134 | 0.060 |
Why?
|
Prognosis | 2 | 2017 | 29625 | 0.060 |
Why?
|
Genomics | 1 | 2021 | 5821 | 0.060 |
Why?
|
Protein Transport | 1 | 2010 | 1967 | 0.060 |
Why?
|
Phosphoprotein Phosphatases | 1 | 2006 | 329 | 0.060 |
Why?
|
Cytoskeletal Proteins | 1 | 2010 | 1342 | 0.060 |
Why?
|
Colon | 1 | 2012 | 1792 | 0.060 |
Why?
|
Aging | 2 | 2015 | 8708 | 0.060 |
Why?
|
Pseudomonas Infections | 1 | 2009 | 622 | 0.060 |
Why?
|
Mice, Knockout | 4 | 2015 | 14414 | 0.060 |
Why?
|
Kidney Neoplasms | 1 | 2021 | 4249 | 0.060 |
Why?
|
Immunohistochemistry | 1 | 2017 | 11076 | 0.060 |
Why?
|
Disease | 1 | 2009 | 672 | 0.060 |
Why?
|
Enzyme Inhibitors | 2 | 2011 | 3712 | 0.060 |
Why?
|
Cell Membrane | 2 | 2010 | 3688 | 0.060 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 2 | 2021 | 1092 | 0.050 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2006 | 687 | 0.050 |
Why?
|
RNA, Small Interfering | 5 | 2011 | 3429 | 0.050 |
Why?
|
Cytoskeleton | 1 | 2008 | 1170 | 0.050 |
Why?
|
Tetradecanoylphorbol Acetate | 3 | 2009 | 817 | 0.050 |
Why?
|
Breast Neoplasms | 4 | 2017 | 21012 | 0.050 |
Why?
|
Intestinal Mucosa | 1 | 2012 | 3032 | 0.050 |
Why?
|
HEK293 Cells | 1 | 2010 | 4278 | 0.050 |
Why?
|
Phosphorylation | 5 | 2011 | 8320 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2019 | 11742 | 0.050 |
Why?
|
Pseudomonas aeruginosa | 1 | 2009 | 1277 | 0.050 |
Why?
|
MAP Kinase Signaling System | 2 | 2018 | 1486 | 0.050 |
Why?
|
Enzyme Activation | 3 | 2016 | 3597 | 0.040 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2022 | 296 | 0.040 |
Why?
|
Colitis, Ulcerative | 1 | 2012 | 1922 | 0.040 |
Why?
|
Apoptosis | 3 | 2011 | 9486 | 0.040 |
Why?
|
Mice, Inbred C57BL | 5 | 2018 | 22169 | 0.040 |
Why?
|
Cystic Fibrosis | 1 | 2009 | 1285 | 0.040 |
Why?
|
Treatment Outcome | 3 | 2019 | 64680 | 0.040 |
Why?
|
Interleukin-6 | 1 | 2009 | 3208 | 0.040 |
Why?
|
T Cell Transcription Factor 1 | 1 | 2018 | 72 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2010 | 10766 | 0.040 |
Why?
|
Retrospective Studies | 2 | 2020 | 80636 | 0.040 |
Why?
|
RNA, Antisense | 1 | 2018 | 136 | 0.040 |
Why?
|
Gene Silencing | 3 | 2009 | 1509 | 0.040 |
Why?
|
Sphingomyelins | 2 | 2009 | 105 | 0.040 |
Why?
|
Macrophages | 1 | 2012 | 5769 | 0.040 |
Why?
|
Mitochondria | 2 | 2007 | 3624 | 0.040 |
Why?
|
Drug Delivery Systems | 1 | 2008 | 2226 | 0.030 |
Why?
|
Carcinogens | 2 | 2009 | 452 | 0.030 |
Why?
|
NIH 3T3 Cells | 1 | 2018 | 670 | 0.030 |
Why?
|
Apyrase | 1 | 2018 | 373 | 0.030 |
Why?
|
Cell Proliferation | 3 | 2018 | 10445 | 0.030 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2022 | 938 | 0.030 |
Why?
|
Aged, 80 and over | 3 | 2018 | 58976 | 0.030 |
Why?
|
RNA Interference | 3 | 2009 | 2831 | 0.030 |
Why?
|
Genes, ras | 1 | 2017 | 654 | 0.030 |
Why?
|
Membrane Proteins | 1 | 2010 | 7856 | 0.030 |
Why?
|
Female | 9 | 2018 | 392644 | 0.030 |
Why?
|
Electroretinography | 1 | 2015 | 525 | 0.030 |
Why?
|
Male | 6 | 2021 | 360804 | 0.030 |
Why?
|
Drug Synergism | 1 | 2017 | 1755 | 0.030 |
Why?
|
Tamoxifen | 1 | 2017 | 965 | 0.030 |
Why?
|
Inflammation | 1 | 2012 | 10773 | 0.030 |
Why?
|
Mice, Nude | 1 | 2018 | 3615 | 0.020 |
Why?
|
Fumonisins | 1 | 2011 | 10 | 0.020 |
Why?
|
Dextran Sulfate | 1 | 2012 | 256 | 0.020 |
Why?
|
Polyribosomes | 1 | 2011 | 109 | 0.020 |
Why?
|
Infant | 1 | 2013 | 36192 | 0.020 |
Why?
|
bcl-2 Homologous Antagonist-Killer Protein | 1 | 2011 | 71 | 0.020 |
Why?
|
Cohort Studies | 1 | 2013 | 41487 | 0.020 |
Why?
|
Child, Preschool | 1 | 2013 | 42230 | 0.020 |
Why?
|
Benzamides | 1 | 2016 | 1370 | 0.020 |
Why?
|
Endotoxins | 1 | 2012 | 520 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2018 | 6216 | 0.020 |
Why?
|
Young Adult | 2 | 2013 | 59243 | 0.020 |
Why?
|
bcl-X Protein | 1 | 2011 | 410 | 0.020 |
Why?
|
Genome | 1 | 2017 | 1740 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2017 | 3602 | 0.020 |
Why?
|
Aged | 3 | 2021 | 169289 | 0.020 |
Why?
|
Time Factors | 1 | 2010 | 39967 | 0.020 |
Why?
|
Middle Aged | 4 | 2018 | 220895 | 0.020 |
Why?
|
Gene Deletion | 1 | 2016 | 2665 | 0.020 |
Why?
|
Adult | 2 | 2013 | 221177 | 0.020 |
Why?
|
Inositol | 1 | 2009 | 215 | 0.020 |
Why?
|
Antigens, CD | 1 | 2018 | 4003 | 0.020 |
Why?
|
Exosomes | 1 | 2012 | 424 | 0.020 |
Why?
|
Cell Survival | 1 | 2017 | 5791 | 0.020 |
Why?
|
Cytochromes c | 1 | 2007 | 173 | 0.020 |
Why?
|
Cell Line | 2 | 2012 | 15601 | 0.020 |
Why?
|
Organ Specificity | 1 | 2011 | 1967 | 0.020 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2016 | 2825 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2018 | 18252 | 0.020 |
Why?
|
Protein Phosphatase 1 | 1 | 2006 | 134 | 0.020 |
Why?
|
Molecular Structure | 1 | 2010 | 1880 | 0.020 |
Why?
|
Interleukin-8 | 1 | 2009 | 695 | 0.020 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2009 | 450 | 0.020 |
Why?
|
Subcellular Fractions | 1 | 2006 | 532 | 0.020 |
Why?
|
Brain | 1 | 2012 | 27112 | 0.020 |
Why?
|
Acute Disease | 1 | 2016 | 7237 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2009 | 1541 | 0.020 |
Why?
|
Child | 1 | 2013 | 80153 | 0.020 |
Why?
|
Cytosol | 1 | 2008 | 888 | 0.020 |
Why?
|
RNA, Messenger | 2 | 2010 | 12795 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2022 | 9606 | 0.010 |
Why?
|
HeLa Cells | 1 | 2010 | 3093 | 0.010 |
Why?
|
Catalytic Domain | 1 | 2006 | 705 | 0.010 |
Why?
|
Pyrimidines | 1 | 2016 | 3028 | 0.010 |
Why?
|
Drug Design | 1 | 2008 | 1048 | 0.010 |
Why?
|
DNA Primers | 1 | 2007 | 2819 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2021 | 22176 | 0.010 |
Why?
|
Cell Cycle | 1 | 2011 | 2932 | 0.010 |
Why?
|
Genetic Vectors | 1 | 2012 | 3395 | 0.010 |
Why?
|
Tandem Mass Spectrometry | 1 | 2009 | 1188 | 0.010 |
Why?
|
Microscopy, Confocal | 1 | 2008 | 1971 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 3810 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2017 | 9420 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2012 | 8181 | 0.010 |
Why?
|
Fibroblasts | 1 | 2011 | 4141 | 0.010 |
Why?
|
Lipid Metabolism | 1 | 2008 | 1902 | 0.010 |
Why?
|
Pancreatic Neoplasms | 1 | 2016 | 5368 | 0.010 |
Why?
|
Bacterial Proteins | 1 | 2010 | 3847 | 0.010 |
Why?
|
Base Sequence | 1 | 2007 | 12441 | 0.010 |
Why?
|
Rats | 1 | 2012 | 23742 | 0.010 |
Why?
|
Cell Movement | 1 | 2008 | 5203 | 0.010 |
Why?
|
Models, Biological | 1 | 2006 | 9469 | 0.010 |
Why?
|